[1]
Y. Wongsalap, “Incidence and Risk Factors of QT Prolongation and Torsades de Pointes following Intravenous Amiodarone Administration for Atrial Fibrillation: A Cohort Study”, Arch Acad Emerg Med, vol. 13, no. 1, p. e70, Sep. 2025.